SCHEMBL7416174

SCHEMBL7416174

O=C(CC(=O)NN1CCOCC1)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.52
LIPE Q05469 2/20 0.52
ALDH1A1 P00352 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C19 P33261 1/20 0.51
HTT P42858 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
CDK5 Q00535 1/20 0.46
CDK5R1 Q15078 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
FKBP1A P62942 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6790329 0.89 SMN1; SMN2 (0.59) SMN1; SMN2LIPEALDH1A1CYP1A2CYP3A4
SCHEMBL7288147 0.76 CPA1 (0.53) SMN1; SMN2ALDH1A1CYP1A2HTTUSP2
Benzenemethanethiol SCHEMBL7371355 0.76 USP2 (0.46) SMN1; SMN2LIPEALDH1A1CYP2C19HTT
SCHEMBL7445195 0.75 LIPE (0.63) LIPEALDH1A1HTTUSP2MAPT
SCHEMBL7287469 0.75 LIPE (0.46) SMN1; SMN2LIPEALDH1A1CYP1A2CYP3A4
SCHEMBL9503176 0.75 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1CYP2C19NPC1RAB9A
SCHEMBL7701320 0.74 KMT2A (0.58) SMN1; SMN2ALDH1A1HTTNPC1RAB9A
SCHEMBL27696449 0.73 HTT (0.57) SMN1; SMN2ALDH1A1HTTNPC1RAB9A
SCHEMBL7536026 0.73 MMP8 (0.45) SMN1; SMN2LIPEALDH1A1CYP1A2HTT
SCHEMBL7536033 0.73 MMP8 (0.45) SMN1; SMN2LIPEALDH1A1CYP1A2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117840-A INHIBITS BINDING BETWEEN VLA-4 RECEPTOR EXPRESSED ON INFLAMMATORY LEUKOCYTES AND FIBRONECTIN CS-1 PEPTIDE EXPRESSED ON ENDOTHELIAL CELLS THAT ARE INVOLVED IN IMMUNOINFLAMMATORY DISEASE STATES CYTEL CORPORATION (US) 2000-09-12 US disclosed
WO-2000002903-A1 CS-1 PEPTIDOMIMETICS, COMPOSITIONS AND METHODS OF USING THE SAME CYTEL CORPORATION (US) 2000-01-20 WO disclosed
US-5936065-A PRODRUG AS ANTIINFLAMMATORY AGENT FOR AUTOIMMUNE DISEASES; FOR SUPPRESSING BINDING OF INFLAMMATORY CELLS TO ENDOTHELIAL CELLS THAT EXPRESS THE CS-1 PORTION OF FIBRONECTIN ON THEIR SURFACES CYTEL CORPORATION (US) 1999-08-10 US disclosed
US-5821231-A TREATMENT OF IMMUNOINFLAMMATORY CONDITIONS CYTEL CORPORATION (US) 1998-10-13 US disclosed
US-5770573-A CS-1 peptidomimetics, compositions and methods of using the same CYTEL CORPORATION (US) 1998-06-23 US disclosed
US-5688913-A OLIGOPEPTIDES AS ANTIINFLAMMATORY AGENTS CYTEL CORPORATION (US) 1997-11-18 US disclosed